-+ 0.00%
-+ 0.00%
-+ 0.00%

TEMPEST SECURES EXCLUSIVE OPTION TO LICENSE CLINICAL-STAGE CD7-TARGETED LENTIVIRAL IN VIVO CAR-T PLATFORM

路透·09/15/2026 20:05:00

登录查看新闻详情